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Background: Estrogen receptors play an important role in mediating estrogen action on target tissues, and the
estrogen is relevant to male infertility. Single nucleotide polymorphisms (SNPs) in estrogen receptors may be
associated with the risk of male infertility. A variety of case control studies have been published evaluating this
association. However, the accumulated studies have shown inconsistent conclusions.
Methods: To further determine the potential association between the four common SNPs (rs2234693, rs9340799,
rs1256049 and rs4986938) in estrogen receptors gene and male infertility, this meta-analysis was performed
according to the 10 published case control studies. The odds ratio (OR) and 95% confidence interval (CI) were used
to evaluate the strength of the associations.
Results: It was revealed that the sub-group analysis by the ethnicity, for the rs2234693, a significant association in
the comparison of CC vs. TT (OR = 0.61, 95% CI: 0.40-0.93), CT vs. TT (OR = 0.67, 95% CI: 0.49-0.93) and CC + CT vs. TT
(OR = 0.66, 95% CI: 0.49-0.89) in the Asian population with male infertility. For rs9340799 polymorphism, increased
risks were observed for the comparison of AA vs. GG (OR = 1.75, 95% CI: 1.15-2.68) and AA vs. GA + GG (OR = 1.38,
95% CI: 1.02-1.88). For rs1256049 polymorphism, the comparison of the GA vs. GG (OR = 1.52, 95% CI: 1.00-2.31)
and AA + GA vs. GG (OR = 1.74, 95% CI: 1.03-2.94), also increased risks present in Asian and Caucasian population,
respectively.
Conclusions: The rs2234693C allele was associated with the decreased risk for male infertility; however, the
rs9340799AA genotype and the rs1256049GA genotype were associated with an increased risk for male infertility.
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Male infertility is an important cause of couple’s inability
to bear children in 20% to 25% of total cases and the eti-
ology of nearly half of the cases remains idiopathic [1,2].
Approximately 15% of male infertile cases, genetic factors,
including chromosomal aberrations and single gene mu-
tations, may result in spermatogenic failure and sperm
dysfunction [3,4]. The traditional view of estradiol as the
‘female’ hormone and of testosterone as the ‘male’ hor-
mone has been challenged due to the increased interest in
elucidating the role of estrogen in males [5]. Estrogens are
produced in the male reproductive system by Sertoli cells,
Leydig cells, and germ cells [6,7]. In addition, studies re-
vealed that estrogens reduce testosterone production from* Correspondence: xinyixia78@gmail.com
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unless otherwise stated.Leydig cells and reduce Sertoli cell numbers in adult when
they are given during development [8,9]. The estrogens
can also disrupt fetal Leydig cell development, inhibit
apoptosis of human postmeiotic germ cells, and increase
spermatogonial number per testis [8-12]. The physical
functions of estrogens were involved in the estrogen re-
ceptors (ERs). Moreover, ERs are members of the nuclear
receptor (NR) superfamily that mediates the pleiotropic
effects of estrogen in a diverse range of developmental
and physiological processes, playing an important role in
mediating estrogen action on target tissues [13,14].
ERs have been identified to be two subtypes of ERα
and ERβ. ERα is a 595-amino acid protein [15] encoded
by the ERs1 gene on chromosome 6q25, and ERβ is a
530-amino acid protein [16] which encoded by the ERs2
gene on chromosome 14q22-24 [17]. Genetic screening
for the ERα gene locus has revealed several polymorphichis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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1(T/C transition, rs2234693) and in 50 bp downstream of
the former one (G/A transition, rs9340799) have been
widely concerned. In addition, the ERβ genes have been
described with two silent G/A polymorphisms (rs1256049
and rs4986938) [19]. To date, epidemiological studies have
been carried out to evaluate the association between ER
polymorphisms and male infertility. However, the results
remain inconsistent (Table 1) [5,7,19-26]. In order to get a
more precise estimation of the association between poly-
morphisms in ERs and risk of male infertility, this meta-
analysis was performed based on ten eligible previously
published studies.Methods
Identification and eligibility of studies
To identify all articles that examined the association of
ERs polymorphisms with male infertility, a comprehen-
sive systematic bibliographic search through the medical
databases PUBMED, attempting to cover all medical
papers published between 1950 and 2013, using the fol-
lowing keywords and subject terms: “male infertility”,
“polymorphism” and “estrogen receptors” or “ERs”. The
synonyms of polymorphism (rs2234693, rs9340799,
rs1256049, and rs4986938) were also used as the key-
words in the search. The studies were excluded if they
were not English language papers or human subject.
References in retrieved articles were screened in which
case reports, meta-analyses and review articles were ex-
cluded. In addition, studies were identified by a manual
search of the references lists of reviews and retrieved
studies. All the studies were included if they met the
following criteria: (I) about the rs2234693, rs9340799,
rs1256049, and rs4986938 polymorphisms and male
infertility, (II) from a case control study, (III) geno-
type frequencies could be derived. The reasons for
exclusion of articles were listed in the Additional file 1:
Text S1.Data extraction
Two authors (Tian-Fu Li and Qiu-Yue Wu) extracted all
data independently that met the inclusion criteria and
reached the consensus for any controversy. The main
characteristics of the enrolled studies were listed in the
Table 1, including: (I) the first author’s last name, (II)
year of publication, (III) ethnicity, (IV) source of control
groups (population- or hospital-based controls), (V)
genotyping methods, (VI) the polymorphism sites, (VII)
characteristics of studies, (VIII) Case/Control counts,
(IX) Hardy–Weinberg equilibrium in the controls. Data
were extracted separately for each ethnic groups catego-
rized as Caucasian and Asian. However, no African was
identified in this study.Statistical analysis
The risk of male infertility associated with the four poly-
morphisms of the ERs gene was estimated for each study
by odds ratio (OR), together with its 95% confidence
interval (CI), respectively. The four polymorphisms were
evaluated for the associations with male infertility sus-
ceptibility based on four genetic models. To contrast,
the wild-type homozygote (WW), we first estimated the
risk of the rare allele homozygote (RR) and heterozygous
(WR) genotypes on infertility, then evaluated the risk of
infertility under a dominant model (RR +WR vs. WW).
In addition, recessive model associations were also esti-
mated (RR vs. WR +WW). Moreover, stratified analyses
were also performed by ethnicity (Asian and Caucasian).
The statistical significance of the pooled OR was deter-
mined with the Z-test and a P-value of <0.05 was con-
sidered significant. Heterogeneity across the studies was
evaluated by Chi-square test based on Q test [27] and
was considered significant if P <0.05.A fixed-effect mo-
del using the Mantel–Haenszel method and a random-
effects model using the DerSimonian and Laird method
were used to pool the results [28]. In addition, the fixed-
effect model was used as well when there was no hetero-
geneity across results of the studies, or the random-effect
model. Moreover, a sensitivity analysis, by which a single
study in the meta-analysis was deleted each time to deter-
mine the influence of the individual data set to the overall
pooled OR, was performed to assess the stability of the re-
sults. To test the publication bias, Funnel plots and Egger’s
linear regression test were applied [29]. Hardy–Weinberg
equilibrium in the controls of each study was calculated
using a web-based program [30]. All statistical tests for
this meta-analysis were performed with STATA version
10.0 (Stata Corporation College Station, TX, USA).Results
Characteristics of studies
A total of 10 eligible case control studies with the publi-
cation dates ranged from 2002 to 2013 met the prespeci-
fied inclusion criteria (shown in the Figure 1), including
five studies of Asian population [19-21,23,24] and five
studies of Caucasian population [5,7,22,25,26]. To deter-
mine the SNPs, two different genotyping methods such
as PCR-RFLP [5,19-26] and TaqMan assays [7] were ap-
plied. All subjects were received comprehensive andro-
logical examination, and the patients were divided into
three types: oligozoospermia (sperm count <20 × 106/mL),
azoospermia and oligoasthenoteratozoospermic (OAT).
The studies’ exclusion criteria and inclusion criteria were
listed in the Table 1. In addition, the sources of controls in
these studies were mainly population-based. The distri-
bution of genotypes in the controls of all studies was con-
sistent with Hardy–Weinberg equilibrium except for the
Table 1 Summary of published studies included




Characteristics of study patients Case/control counts HWE
(Control)




Age: 25–38 years (mean age 32.1 ± 5.2 years). Exclusion criteria:
abnormal karyotypes, deletions of the Y chromosome, orchitis,
varicocele, cryptorchidism, congenital bilateral absence of the vas
deferens, hypogonadotropic hypogonadism, and iatrogenic
infertility.






Zalata [5] 2013 Caucasian PB PCR-RFLP rs2234693,
rs9340799
Inclusion criteria: same ethnic origin (Caucasians). Exclusion
criteria: varicocele, hormonal therapy, hypogonadism, smoking, Y
chromosome deletions and karyotype abnormalities. The ages of
were not shown in the article.
TT:33/14, CT:32/27, CC:16/19; AA:28/8,
AG:36/32, GG: 17/20
0.468, 0.389
Ogata [20] 2012 Asian PB PCR-RFLP rs1256049 Age: 32–52 years (median 41.0 years). Inclusion criteria: no
extragenital anomalies, seminal tract obstruction, varicocele, Y
chromosomal microdeletion, or retrograde ejaculation; normal
karyotypes.
GG:68/64, AG:49/45, AA:8/10 0.604






Age: 36.1 ± 6.5 years. Exclusion criteria: chromosome anomalies,
azoospermia factor (AZF) microdeletions, smoking, alcoholism,
occupation, varicocele, and cryptorchidism.
TT:30/37, CT:93/111, CC:64/68; AA:80/
100, AG:79/88, GG:20/28; GG:172/201,








Age: 31.6 ± 4.8 years (range 25–40 years). Inclusion criterion: two
years with no reason for their infertility. Exclusion criteria:
varicocele or testicular torsion, urinary tract infections,
endocrinopathy, karyotype anomalies, Y-chromosome
microdeletions, use of drugs, leukocytospermia, a BMI of
30 kg/m2 or greater.
TT:49/33, CT:70/86, CC:45/45; AA:62/41,
AG:77/95, GG:25/28; GG:142/152,








Age: 33.2 ± 67.5 years. Exclusion criteria: hypogonadotropic
hypogonadism, obstructive syndromes of the seminal tract,
microdeletions of the Y chromosome, karyotypic abnormalities.
TT:6/20, CT:14/40, CC:9/25; AA:5/13,
AG:13/43, GG:11/29; GG:26/80, AG:3/5,
AA:0/0; GG:7/17, AG:12/36, AA:10/32
0.609, 0.652,
0.779, 0.246
Khattri [23] 2007 Asian PB PCR-RFLP rs1256049 Age: 23.24 ± 2.06 years. Exclusion criteria: obstruction,
endocrinological defect, injuries, karyotypic abnormality,
Y-chromosome microdeletions.
GG:397/231, AG:46/21, AA:0/0 0.490
Omrani [24] 2005 Asian PB PCR-RFLP rs1256049,
rs4986938
Exclusion criteria: genetic causes of infertility, such as Klinefelter
syndrome or Ychromosome microdeletions. The ages of patients
were no shown in the article.
GG:103/194, AG:17/9, AA:0/1; GG:51/86,
AG:57/88,AA:12/30
0.023, 0.339
Aschim [25] 2005 Caucasian PB PCR-RFLP rs1256049,
rs4986938
Exclusion criteria: Klinefelter syndrome or Y-chromosome
microdeletions, a history of cryptorchidism were excluded.
The ages of patients were no shown in the article.
GG:92/177, AG:14/8, AA:0/1; GG:11/82,
AG:48/79, AA:47/25
0.015, 0.394
Kukuvitis [26] 2002 Caucasian PB PCR-RFLP rs2234693,
rs9340799
Exclusion criteria: any known aetiologies (varicocele, infections of
accessory glands, cryptorchidism, homozygous form of
β-thalassemia). The ages of patients were no shown in the article.
TT:38/18, CT:38/25, CC:33/21; AA:30/10,
AG:45/28, GG:34/26
0.083, 0.594
















Figure 1 Flow chart of studies identified with inclusion and exclusion criteria.
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and rs1256049, study [24] in rs 1256049 and study
[25] in rs1256049, which were tested in the sensitivity
analyses.
Quantitative synthesis
Wide variation of four polymorphisms allele frequencies
across different ethnicities was observed. For rs2234693,
the frequency of T allele was 53.13% (95% CI: 49.74-
56.52) in the Asian controls, which was higher than that
in Caucasian controls 44.82% (95% CI: 41.48-48.16) as
shown in Figure 2A. For rs9340799, the frequency of G
allele in the Asian controls (32.45%, 95% CI: 29.27-35.63)
was lower than that in Caucasian controls (46.71%,
95% CI: 43.36-50.06) as shown in Figure 2B. In Figure 2C,
we could find that the frequency of G allele for the
rs1256049 in the Asian controls (87.34%, 95% CI:
85.88-88.81) was lower than which in Caucasian con-
trols (96.92%, 95% CI: 95.82-98.02). In contrast, the
frequency of G allele in Caucasian controls (48.46%,
95% CI: 45.32-51.60) was lower than that in Asian group
(73.39%, 95% CI: 70.93-75.85) for the rs4986938 in
Figure 2D.
For rs2234693 polymorphism, significant differences
were observed for the comparison of CC vs. TT, CT vs.
TT and CC + CT vs. TT. Sub-group analysis by the eth-
nicity revealed a significant association in the com-
parison of CC vs. TT (OR = 0.61, 95% CI: 0.40-0.93,Pheterogeneity = 0.670), CT vs. TT (OR = 0.67, 95% CI:
0.49-0.93, Pheterogeneity = 0.358), CC + CT vs. TT (OR =
0.66, 95% CI: 0.49-0.89, Pheterogeneity = 0.593) and C alleles
vs. T alleles (OR = 0.78, 95% CI: 0.64-0.96, Pheterogeneity =
0.681) in the Asian population, as summarized in
Table 2.
For rs9340799 polymorphism, increased risks were
observed for the comparison of AA vs. GG and AA
vs. GA + GG. Sub-group analysis by ethnicity revealed
increased risks (AA vs. GG: OR = 1.75, 95% CI: 1.15-
2.68, Pheterogeneity = 0.174; AA vs. GA + GG: OR = 1.38,
95% CI: 1.02-1.88, Pheterogeneity = 0.062) in the Caucasian
population, also for the AA vs. GA +GG and A alleles vs.
G alleles, a significant association was observed in Asian
population (OR = 1.93, 95% CI: 1.42-2.62, Pheterogeneity =
0.768; OR = 1.49, 95% CI: 1.18-1.87, Pheterogeneity = 0.375)
as summarized in Table 3.
For rs1256049 polymorphism, significant differences
were observed for the comparison of GA vs. GG, AA +
GA vs. GG and AA vs. GA +GG. For the comparison of
the GA vs. GG, AA +GA vs. GG, increased risks present in
Asian and Caucasian population, respectively (GA vs. GG:
OR = 1.52, 95% CI: 1.00-2.31, Pheterogeneity = 0.038; AA +
GA vs. GG: OR = 1.74, 95% CI: 1.03-2.94, Pheterogeneity =
0.275). All data were concluded in the Table 4. In contrast,
a decreased risk was also observed for the comparison AA
vs. GA+GG (OR = 0.55, 95% CI: 0.31-0.97, Pheterogeneity =
0.818) in Asian population. For the rs4986938, there was
Figure 2 The allel frequencies of the four polymorphisms in the controls may vary by ethnicity. (A) rs2234693, (B) rs9340799, (C) rs1256049,
(D) rs4986938. Star or dot denotes outliers.
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were not shown).
Test of heterogeneity
Among the four polymorphisms, a significant hetero-
geneity was apparent among heterozygote comparison
for the rs1256049 (GA vs. GG: Pheterogeneity = 0.047)
(Figure 3). Two studies [7,19] were identified to con-
tribute to substantial heterogeneity, and it was decreased
when the study was removed respectively (P = 0.065,
P = 0.075). Sensitivity analysis revealed that the two inde-
pendent studies [7,23] were the main cause of heterogen-
eity for the rs1256049. Heterogeneity was decreased when
these studies were removed (GA vs. GG: Pheterogeneity =
0.320, I2 = 14.7%). Although the genotype distributions in
four studies did not follow Hardy–Weinberg equilibrium,
the corresponding pooled ORs were not materially altered
by excluding the studies.Publication bias
Begg’s funnel plot and Egger’s test were performed to as-
sess the publication bias of the currently available litera-
ture. For the rs2234693, rs9340799 and rs4986938, the
shape of the funnel plots did not reveal any evidence of
obvious asymmetry in all comparison models. Then, the
Egger’s test was used to provide statistical evidence for
funnel plot symmetry. The results also did not show any
evidence of publication bias. However, for the rs1256049,
as shown in the Figure 4, the shape of the funnel plots
seemed asymmetrical in the heterozygote and dominant
comparisons, suggesting the presence of publication bias.
Then, the Egger’s tests were adopted to provide statis-
tical evidence of funnel plot asymmetry. As expected,
the results showed obvious evidence of publication bias
(t = 2.53, P = 0.044 for GA vs. GG; t = 2.71, P = 0.035 for
AA + GA vs. GG). To adjust for this bias, a trim-and-
fill method developed by Duval and Tweedie [31] was
Table 2 Stratification analyses of genetic susceptibility of rs2234693 polymorphism to male infertility
Category Cases/
controls
CC vs. TT CT vs. TT CC + CT vs. TT CC vs. CT + TT C allele vs. T allele
OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2
Total 774/841 0.72(0.54-0.96) 0.282 20.1 0.74(0.58-0.94) 0.533 0 0.73(0.58-0.91) 0.368 7.5 0.90(0.71-1.13) 0.465 0 0.84(0.71-1.01) 0.190 32.8
RACE
Asian 368/416 0.61(0.40-0.93) 0.670 0 0.67(0.49-0.93) 0.358 0 0.66(0.49-0.89) 0.593 0 0.83(0.58-1.18) 0.257 22.1 0.78(0.64-0.96) 0.681 0
Caucasian 406/425 0.83(0.46-1.23) 0.175 39.5 0.83(0.57-1.19) 0.460 0 0.81(0.58-1.14) 0.232 30 0.95(0.70-1.29) 0.395 0 0.87(0.64-1.18) 0.103 51.5
I2: 0–25, no heterogeneity; 25–50, modest.
aP value of Q-test for heterogeneity test.
















Table 3 Stratification analyses of genetic susceptibility of rs9340799 polymorphism to male infertility
Category Cases/
controls
AA vs. GG GA vs. GG AA + GA vs. GG AA vs. GA + GG A allele vs. G allele
OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2
Total 774/841 1.67(1.21-2.32) 0.392 3.9 1.03(0.76-1.39) 0.764 0 1.27(0.96-1.68) 0.796 0 1.63(1.32-2.03) 0.077 49.7 1.39(1.13-1.68) 0.172 35.3
RACE
Asian 368/416 1.56(0.93-2.62) 0.714 0 0.81(0.49-1.34) 0.524 0 1.13(0.71-1.82) 0.952 0 1.93(1.42-2.62) 0.768 0 1.49(1.18-1.86) 0.375 0
Caucasian 406/425 1.75(1.15-2.68) 0.174 39.7 1.17(0.81-1.71) 0.847 0 1.35(0.95-1.92) 0.569 0 1.38(1.02-1.88) 0.062 59.2 1.39(0.97-1.81) 0.109 50.5
aP value of Q-test for heterogeneity test.
I2: 0–25, no heterogeneity; 25–50, modest heterogeneity; 50, high heterogeneity.
















Table 4 Stratification analyses of genetic susceptibility of rs1256049 polymorphism to male infertility
Category Cases/Controls AA vs. GG GA vs. GG AA + GA vs. GG AA vs. GA + GG A allele vs. G allele
OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2 OR(95% CI) Pa I2
Total 1378/1478 0.57(0.32-1.01) 0.940 0 1.59(1.12-2.25)b 0.047 50.9 1.30(1.05-1.61) 0.075 45.7 0.55(0.32-0.96) 0.920 0 1.29(0.97-1.72) 0.068 46.9
RACE
Asian 1056/991 0.57(0.32-1.01) 0.853 0 1.52(1.00-2.31)b 0.038 60.6 1.23(0.98-1.56) 0.064 55 0.55(0.31-0.97) 0.818 0 1.19(0.86-1.65) 0.067 54.4
Caucasian 322/487 0.64(0.03-15.86) - - 1.87(0.92-3.80) 0.208 36.2 1.74(1.03-2.94) 0.275 22.6 0.58(0.02-14.38) - - 1.66(0.99-2.77) 0.372 0
aP value of Q-test for heterogeneity test.
bRandom-effects model was used when a P value, 0.05 for heterogeneity test; otherwise, fixed-effects model was used.
I2: 0–25, no heterogeneity; 25–50, modest heterogeneity; 50, high heterogeneity.
















Figure 3 Forest plot for the overall association between rs1256049 polymorphism and male infertility for random effects. For GA vs. GG
each study was shown by the point estimate of the OR (the size of the square is proportional to the weight of each study) and 95% CI for the OR
(extending lines); the pooled OR and 95% CI were shown by diamonds.
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del, and the adjusted estimates obtained by using the ran-
dom effects model were ORs of 1.17 (0.78-1.74) for
GA vs. GG and 1.08 (0.75-1.54) for AA + GA vs. GG
in the Figure 5. Although Meta-analysis with or with-
out the trim-and-fill method also ends up with same
conclusions, but the ORs were not statistically signifi-
cant difference. So it was indicated that the results of
these studies were not statistically robust.
Discussion
The present meta-analysis, including 1568 cases and 1602
controls from 10 case control studies, explored the associ-
ation between the ERs polymorphisms and male infertility.
The results indicated that rs2234693C allele was associ-
ated with decreased risk of the male infertility, particularly
in the Asian population. In contrast, rs9340799AA geno-
type was observed as a risk factor for infertility in both
Asian and Caucasian population, and rs1256049GA ge-
notype was associated with an increased risk for develop-
ing male sterility. However, the rs4986938 polymorphism
was not associated with male infertility. In addition, we
tried to find the data in the available database, suchas PUBMED [32], National Human Genome Research
Institute GWAS Catalog [33] and GWAS Central [34], but
we found no relevant genome-wide association (GWAS)
study about these four polymorphisms.
Estradiol has been reported as a survival factor for
germ cells [11], involving in the induction of oxidative
DNA damage, and the aberrant level of estrogen may
lead to impaired sperm production [35-37]. It has been
shown that free radicals inhibit steriodogenesis by inter-
fering with cholesterol transport to the mitochondria
and/or the catalytic function of P450 enzymes, which
leads to an increase in lipid per oxidation and decline in
the antioxidant barrier [38]. Moreover, estrogens can regu-
late mitochondrial function by increasing nuclear respira-
tory factor-1 (NRF-1) expression [5]. Specifically, estradiol
stimulates mitochondrial function through a genomic me-
chanism of ER action involving direct ERα and ERβ inter-
action with an oestrogen response element in the NRF-1
promoter [39]. In vivo knockdown experiments have in-
dicated that estradiol stimulates NRF-1 transcription and
consequently increases mitochondrial biogenesis through
ERα activity but not through ERβ activity in MCF-7 breast
cells [40]. This findings indicates that ERα polymorphisms
Figure 4 Begg’s funnel plot of publication bias test for the rs1256049. (A) GA vs. GG. (B) AA + GA vs. GG. Each point represents a separate
study for the indicated association. Log (OR), natural logarithm of OR. Horizontal line means effect size.
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tion in human ejaculated spermatozoa, presenting them
with high motility [22].
The mechanisms behind altered ERs function in sub-
jects with polymorphisms remain unclear. The polymor-
phism rs1256049 located at the splice acceptor site just
prior to exon 8 in ERβ [41] and may potentially affect
the splicing of this exon, leading to proteins with differ-
ent properties than the wild-type ERβ [42,43]. In addi-
tion, studies have reported the polymorphism could also
have a direct effect through changing the nucleotide se-
quence and thereby the secondary structure of the ERβ
mRNA, possibly leading to changes the function of mRNA
[44,45]. It has been reported that ERα gene polymor-
phisms (rs2234693 and rs9340799) may modalate the ef-
fect of oestradiol on CYP19, which encodes aromatase
expression, disrupting the gene causes a decline in sperm
numbers and loss of male infertility [46,47].The precise role of estrogen receptors in male fertility
status is understood. Some findings suggest that specific
polymorphisms of the ERα, and ERβ genes which confer
a lower sex hormone binding globulin (SHBG) and thus
a stronger unbound estrogen effect, may adversely affect
human spermatogenesis [48,49]. SHBG is involved in
both delivering reproductive hormones to target tissues
and controlling the concentration of androgens and es-
trogens in the serum and tissues [50]. Pavlovich et al.
[51] demonstrated that infertile men with severe oligo-
zoospermia had significantly lower T (testosterone) and
higher E2 (estradiol) concentrations than fertile control
subjects, resulting in an elevated T/E2 ratio.
Identifying the source of heterogeneity is one of the
most important goals of the meta-analysis. Thus, we stra-
tified the studies only according to ethnicity (because the
sources of the controls were selected through population-
based, and the method used was the only one different).
Figure 5 Begg’s funnel plot of publication bias test for the rs1256049 using the trim-and-fill method. (A) GA vs. GG. (B) AA + GA vs. GG.
Each point represents a separate study for the indicated association. Log (OR), natural logarithm of OR. Horizontal line means effect size. The
adjusted estimates obtained by using the random effects model for GA vs. GG and AA + GA vs. GG.
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difference between the European population and Asian
population, suggesting that different ethnicities and en-
vironmental exposures may have no influence on the sus-
ceptibility of male infertility, and more studies should be
accumulated to reveal the difference. In addition, for the
rs1256049, sensitivity analysis revealed that the three inde-
pendent studies [7,22,23] were the main source of hetero-
geneity. Heterogeneity was decreased when these studies
were removed. For these three studies, the sample size
was not sufficient and the numbers of rs1256049AA geno-
type was both zero. These two points may be the main
reason for the heterogeneity in the performed analysis.
For the rs1256049, there was obvious evidence of publica-
tion bias. As the same with heterogeneity, the numbers of
the cases and controls of the wild-type homozygote in
these three studies [7,22,23] were too small to keep theresults statistically robust, so it maybe the key factor for
the bias. Using a proper and representative subject is very
important in reducing bias in such genotype association
studies.
There are still some limitations in this meta-analysis.
Firstly, there were only ten literatures enrolled in this
meta-analysis, the sample size was not big enough to have
substantial power exploring the real association. Secondly,
the detailed information (such as life-style, age, and work)
could not be traced, so that our unadjusted estimates
should be confirmed by further studies. In addition, an in-
dividual with a clinical disorder was not a result of the sin-
gle gene that is disrupted, but that the genetic disruption
was embedded within the context of that individual's en-
tire genome and environment exposure [52]. In fact, some
other genes related to fertility could also play an important
role in spermatogenesis.
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In summary, this meta-analysis suggested that the
rs2234693C allele was the protective factor for male
infertility, the rs9340799AA genotype was associated with
an increased risk for infertility, and the rs1256049GA
genotype was also the negative factor.
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